Text to be removed highlighted in red.
277:1 Coverage for Certain Biologically-Based Mental Illnesses. Amend RSA 417-E:1, II to read as follows:
II. Notwithstanding any other provision of law, each insurer that issues or renews any policy of group accident or health insurance and each nonprofit health service corporation under RSA 420-A and health maintenance organization under RSA 420-B providing benefits for disease or sickness in the state of New Hampshire shall provide benefits for treatment and diagnosis of certain biologically-based mental illnesses under the same terms and conditions and which are no less extensive than coverage provided for any other type of health care for physical illness.
277:2 Coverage for Certain Biologically-Based Mental Illnesses. Amend RSA 417-E:1, III(f) to read as follows:
(f) Obsessive-compulsive disorder .
277:3 Coverage for Certain Biologically-Based Mental Illnesses. RSA 417-E:1, III(f) is repealed and reenacted to read as follows:
(f) Obsessive-compulsive disorder, including pediatric autoimmune neuropsychiatric disorders.
277:4 Effective Date.
I. Section 3 of this act shall take effect July 1, 2024.
II. The remainder of this act shall take effect 60 days after its passage.
Approved: July 19, 2019
Effective Date:
I. Section 3 shall take effect July 1, 2024.
II. Remainder shall take effect September 17, 2019.
Text to be added highlighted in green.
277:1 Coverage for Certain Biologically-Based Mental Illnesses. Amend RSA 417-E:1, II to read as follows:
II. Notwithstanding any other provision of law, each insurer that issues or renews any policy of accident or health insurance and each nonprofit health service corporation under RSA 420-A and health maintenance organization under RSA 420-B providing benefits for disease or sickness in the state of New Hampshire shall provide benefits for treatment and diagnosis of certain biologically-based mental illnesses under the same terms and conditions and which are no less extensive than coverage provided for any other type of health care for physical illness.
277:2 Coverage for Certain Biologically-Based Mental Illnesses. Amend RSA 417-E:1, III(f) to read as follows:
(f) Obsessive-compulsive disorder , including pediatric autoimmune neuropsychiatric disorders, when treatment, including the use of intravenous immunoglobulin therapy, is ordered by a physician .
277:3 Coverage for Certain Biologically-Based Mental Illnesses. RSA 417-E:1, III(f) is repealed and reenacted to read as follows:
(f) Obsessive-compulsive disorder, including pediatric autoimmune neuropsychiatric disorders.
277:4 Effective Date.
I. Section 3 of this act shall take effect July 1, 2024.
II. The remainder of this act shall take effect 60 days after its passage.
Approved: July 19, 2019
Effective Date:
I. Section 3 shall take effect July 1, 2024.
II. Remainder shall take effect September 17, 2019.